Armata Pharmaceuticals Inc (ARMP)
2.59
-0.06
(-2.26%)
USD |
NYAM |
May 17, 16:00
2.64
+0.05
(+1.93%)
After-Hours: 20:00
Armata Pharmaceuticals Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.015M |
| December 31, 2016 | |
| September 30, 2016 | 0.024M |
| June 30, 2016 | 0.018M |
| March 31, 2016 | 0.014M |
| December 31, 2015 | 0.125M |
| September 30, 2015 | 0.04M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.10M |
| September 30, 2014 | 0.027M |
| June 30, 2014 | 0.136M |
| March 31, 2014 | 0.012M |
| December 31, 2013 | 0.008M |
| September 30, 2009 | 0.007M |
| June 30, 2009 | 0.129M |
| March 31, 2009 | 0.257M |
| December 31, 2008 | 0.317M |
| September 30, 2008 | 0.368M |
| June 30, 2008 | 0.255M |
| March 31, 2008 | 2.06M |
| December 31, 2007 | 2.611M |
| September 30, 2007 | 1.544M |
| Date | Value |
|---|---|
| June 30, 2007 | 1.874M |
| March 31, 2007 | 0.944M |
| December 31, 2006 | 1.498M |
| September 30, 2006 | 0.613M |
| June 30, 2006 | 0.29M |
| March 31, 2006 | 0.991M |
| December 31, 2005 | 0.38M |
| September 30, 2005 | 0.611M |
| June 30, 2005 | 0.124M |
| March 31, 2005 | 0.104M |
| December 31, 2004 | 0.404M |
| September 30, 2004 | 0.001M |
| June 30, 2004 | |
| March 31, 2004 | 0.008M |
| December 31, 2003 | 0.166M |
| September 30, 2003 | 0.025M |
| June 30, 2003 | 0.007M |
| March 31, 2003 | |
| December 31, 2002 | 1.17M |
| September 30, 2002 | 1.626M |
| June 30, 2002 | 3.197M |
| March 31, 2002 | 3.081M |
| December 31, 2001 | 2.475M |
| September 30, 2001 | 0.7342M |
| June 30, 2001 | 2.312M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -- |
| Perspective Therapeutics Inc | 0.999M |
| Protalix BioTherapeutics Inc | 3.759M |
| Electromed Inc | 23.91M |
| Xtant Medical Holdings Inc | 21.48M |